SCHEMBL6559920

SCHEMBL6559920

O=C1CCCCN(S(=O)(=O)c2ccccn2)C1

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PKM P14618 2/20 0.44
PKLR P30613 1/20 0.44
CYP3A4 P08684 2/20 0.42
CYP2C9 P11712 1/20 0.42
TSHR P16473 1/20 0.42
CYP2C19 P33261 1/20 0.42
KDM4E B2RXH2 2/20 0.41
COMT P21964 2/20 0.40
RAB9A P51151 5/20 0.38
NPC1 O15118 2/20 0.38
ALDH1A1 P00352 2/20 0.38
HTR6 P50406 1/20 0.38
CTSL P07711 4/20 0.37
CTSS P25774 4/20 0.37
CTSK P43235 3/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
CTSB P07858 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1847833 0.85 PKM (0.56) PKMPKLRCYP3A4CYP2C9TSHR
SCHEMBL6616459 0.83 TSHR (0.56) PKMPKLRCYP3A4CYP2C9TSHR
SCHEMBL12655896 0.80 PKM (0.52) PKMPKLRCYP3A4CYP2C9TSHR
SCHEMBL21772096 0.79 PKM (0.45) PKMPKLRCYP3A4TSHRKDM4E
SCHEMBL5093011 0.79 PKM (0.43) PKMPKLRCYP3A4CYP2C9TSHR
SCHEMBL4768241 0.76 CTSK (0.45) PKMPKLRCTSLCTSSCTSK
SCHEMBL8336654 0.76 CTSK (0.45) PKMPKLRHTR6CTSLCTSS
SCHEMBL6559756 0.74 TSHR (0.38) CYP3A4CYP2C9TSHRCYP2C19KDM4E
SCHEMBL6559984 0.74 KMT2A (0.62) PKMPKLRCYP3A4CYP2C9TSHR
SCHEMBL8334693 0.73 CTSK (0.44) CTSLCTSSCTSKCTSB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1436255-A1 NOVEL COMPOUNDS AND COMPOSITIONS AS CATHEPSIN INHIBITORS Aventis Pharmaceuticals, Inc. (US) 2004-07-14 EP disclosed
WO-2004017911-A2 PROTEASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2004-03-04 WO disclosed
WO-2003024924-A1 NOVEL COMPOUNDS AND COMPOSITIONS AS CATHEPSIN INHIBITORS AVENTIS PHARMACEUTICALS INC. (US) 2003-03-27 WO disclosed